tiprankstipranks
AbbVie upgraded to Outperform from Market Perform at Leerink
The Fly

AbbVie upgraded to Outperform from Market Perform at Leerink

Leerink upgraded AbbVie (ABBV) to Outperform from Market Perform with a $206 price target

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App